|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ch. 373
|
|
2002 LAWS OF MARYLAND
|
|
|
|
|
|
|
|
|
|
(3) MAY NOT HAVE A HOUSEHOLD MEMBER WHO IS A HEALTH CARE
PROFESSIONAL OR IS IN TRAINING TO BE A HEALTH CARE PROFESSIONAL; AND
(4) MAY NOT:
(I) PARTICIPATE IN A COMMERCIAL OR PROFESSIONAL FIELD
RELATED TO HAVE A SUBSTANTIAL PERSONAL, BUSINESS, PROFESSIONAL, OR
PECUNIARY CONNECTION WITH A MEDICAL FIELD, AN INSTITUTION OF MEDICAL
EDUCATION, OR A HEALTH CARE FACILITY;
(II) HAVE A HOUSEHOLD MEMBER WHO PARTICIPATES IN A
COMMERCIAL OR PROFESSIONAL FIELD RELATED TO HEALTH CARE; OR
(III) HAVE HAD WITHIN 2 YEARS BEFORE APPOINTMENT A
FINANCIAL INTEREST IN A PERSON REGULATED BY THE BOARD.
(C) (E) (1) THE TERM OF A MEMBER IS 3 YEARS.
(2) THE TERMS OF MEMBERS ARE STAGGERED AS REQUIRED BY THE
REGULATIONS ADOPTED BY THE BOARD IN 1999 REGULATION.
(3) AT THE END OF A TERM, A MEMBER CONTINUES TO SERVE UNTIL A
SUCCESSOR IS APPOINTED AND QUALIFIES.
(4) A MEMBER MAY NOT SERVE MORE THAN 2 CONSECUTIVE FULL
TERMS.
14-4B-06.
IN ADDITION TO THE POWERS SET FORTH ELSEWHERE IN THIS SUBTITLE, THE
COMMITTEE SHALL.
(1) MAKE RECOMMENDATIONS TO THE BOARD ON REGULATIONS
NECESSARY TO CARRY OUT THE PROVISIONS OF THIS SUBTITLE;
(2) MAKE RECOMMENDATIONS TO THE BOARD ON A CODE OF ETHICS
FOR THE PRACTICE OF MEDICAL RADIATION TECHNOLOGY AND NUCLEAR MEDICINE
TECHNOLOGY FOR ADOPTION BY THE BOARD;
(3) MAKE RECOMMENDATIONS TO THE BOARD ON THE REQUIREMENTS
FOR CERTIFICATION AS A RADIATION ONCOLOGY/THERAPY TECHNOLOGIST,
MEDICAL RADIATION TECHNOLOGIST, OR CERTIFICATION AS A NUCLEAR MEDICINE
TECHNOLOGIST;
(4) (3) REVIEW APPLICATIONS FOR CERTIFICATION AS A RADIATION
ONCOLOGY/THERAPY TECHNOLOGIST, MEDICAL RADIATION TECHNOLOGIST, OR
NUCLEAR MEDICINE TECHNOLOGIST, IF REQUESTED, AND MAKE
RECOMMENDATIONS TO THE BOARD;
(5) (4) AT THE REQUEST OF THE BOARD, INVESTIGATE COMPLAINTS
AGAINST CERTIFIED RADIATION ONCOLOGY/THERAPY TECHNOLOGISTS. CERTIFIED
MEDICAL RADIATION TECHNOLOGISTS, AND CERTIFIED NUCLEAR MEDICINE
TECHNOLOGISTS;
|
|
|
|
|
|
|
|
|
|
- 2976 -
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
